Discovery and Development Programs

R&D Pipeline

Gubra’s robust R&D pipeline is centered on the discovery and development of peptide-based therapeutics. Fueled by our proprietary StreaMLine platform, we are advancing a growing portfolio across diverse therapeutic areas, including including metabolic, endocrine, and rare disorders. Our approach is rooted in deep peptide expertise and supported by a broad platform of validated and translational in vivo models.

Leading in peptides

• AI, machine learning, and high-throughput screening to rapidly transform peptide hits into optimized, IP-protected development candidates
• Expertise across metabolic, fibrotic, inflammatory, CNS, respiratory, and women’s health
• Deep scientific knowledge combined with translational in vivo models, ultimately building confidence early in clinical development.